Literature DB >> 21298161

Role of metal dyshomeostasis in Alzheimer's disease.

David J Bonda1, Hyoung-gon Lee, Jeffrey A Blair, Xiongwei Zhu, George Perry, Mark A Smith.   

Abstract

Despite serving a crucial purpose in neurobiological function, transition metals play a sinister part in the aging brain, where the abnormal accumulation and distribution of reactive iron, copper, and zinc elicit oxidative stress and macromolecular damage that impedes cellular function. Alzheimer's disease (AD), an age-related neurodegenerative condition, presents marked accumulations of oxidative stress-induced damage, and increasing evidence points to aberrant transition metal homeostasis as a critical factor in its pathogenesis. Amyloid-β oligomerization and fibrillation, considered by many to be the precipitating factor underlying AD onset and development, is also induced by abnormal transition metal activity. We here elaborate on the roles of iron, copper, and zinc in AD and describe the therapeutic implications they present.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298161      PMCID: PMC3117398          DOI: 10.1039/c0mt00074d

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  45 in total

1.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

Authors:  X Zhu; R J Castellani; A Takeda; A Nunomura; C S Atwood; G Perry; M A Smith
Journal:  Mech Ageing Dev       Date:  2001-12       Impact factor: 5.432

2.  In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.

Authors:  L M Sayre; G Perry; P L Harris; Y Liu; K A Schubert; M A Smith
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

3.  Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro.

Authors:  R N Alyaudtin; A Reichel; R Löbenberg; P Ramge; J Kreuter; D J Begley
Journal:  J Drug Target       Date:  2001-06       Impact factor: 5.121

Review 4.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 5.  Nanoparticulate systems for brain delivery of drugs.

Authors:  J Kreuter
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

Review 6.  The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.

Authors:  George Perry; Lawrence M Sayre; Craig S Atwood; Rudolph J Castellani; Adam D Cash; Catherine A Rottkamp; Mark A Smith
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease.

Authors:  M Takahashi; S Doré; C D Ferris; T Tomita; A Sawa; H Wolosker; D R Borchelt; T Iwatsubo; S H Kim; G Thinakaran; S S Sisodia; S H Snyder
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

Review 8.  Mapping brain metals to evaluate therapies for neurodegenerative disease.

Authors:  Bogdan Florin Gh Popescu; Helen Nichol
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

9.  Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Authors:  Jörg Kreuter; Dmitry Shamenkov; Valery Petrov; Peter Ramge; Klaus Cychutek; Claudia Koch-Brandt; Renad Alyautdin
Journal:  J Drug Target       Date:  2002-06       Impact factor: 5.121

10.  An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.

Authors:  Jack T Rogers; Jeffrey D Randall; Catherine M Cahill; Paul S Eder; Xudong Huang; Hiromi Gunshin; Lorene Leiter; Jay McPhee; Satinder S Sarang; Tada Utsuki; Nigel H Greig; Debomoy K Lahiri; Rudolph E Tanzi; Ashley I Bush; Tony Giordano; Steve R Gullans
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

View more
  64 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  AMPK Inhibition Enhances the Neurotoxicity of Cu(II) in SH-SY5Y Cells.

Authors:  Ai-Ping Lan; Xian-Jia Xiong; Jun Chen; Xi Wang; Zhi-Fang Chai; Yi Hu
Journal:  Neurotox Res       Date:  2016-07-19       Impact factor: 3.911

3.  A sensitive colorimetric and ratiometric chemosensor for trivalent metal cations.

Authors:  Xu Zhao; Guohui Yin; Di Jin; Xilong Yan; Yang Li; Ligong Chen
Journal:  J Fluoresc       Date:  2015-02-10       Impact factor: 2.217

Review 4.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

5.  Pyrene Based Fluorescent Turn-on Chemosensor for Sequential Detection of Fe3+ and Fe2+ Ions and its Application in Live Cell Imaging.

Authors:  Rajasekaran Dhivya; Asaithambi Gomathi; Periasamy Viswanathamurthi
Journal:  J Fluoresc       Date:  2019-06-07       Impact factor: 2.217

6.  Dialing in on pharmacological features for a therapeutic antioxidant small molecule.

Authors:  Kayla N Green; Kristof Pota; Gyula Tircsó; Réka Anna Gogolák; Olivia Kinsinger; Collin Davda; Kimberly Blain; Samantha M Brewer; Paulina Gonzalez; Hannah M Johnston; Giridhar Akkaraju
Journal:  Dalton Trans       Date:  2019-07-25       Impact factor: 4.390

7.  Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery.

Authors:  Manojkumar Jadhao; Chayan Das; Anoop Rawat; Himank Kumar; Ritika Joshi; Sudipta Maiti; Sujit Kumar Ghosh
Journal:  J Biol Inorg Chem       Date:  2016-11-07       Impact factor: 3.358

8.  Iron supplementation dose for perinatal iron deficiency differentially alters the neurochemistry of the frontal cortex and hippocampus in adult rats.

Authors:  Raghavendra Rao; Ivan Tkac; Erica L Unger; Kathleen Ennis; Amy Hurst; Timothy Schallert; James Connor; Barbara Felt; Michael K Georgieff
Journal:  Pediatr Res       Date:  2012-10-24       Impact factor: 3.756

9.  Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols.

Authors:  Lynne M Hyman; Katherine J Franz
Journal:  Coord Chem Rev       Date:  2012-10-01       Impact factor: 22.315

Review 10.  Opportunities in multidimensional trace metal imaging: taking copper-associated disease research to the next level.

Authors:  Stefan Vogt; Martina Ralle
Journal:  Anal Bioanal Chem       Date:  2012-10-19       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.